Model-Based Prediction of Plasma Concentration and Enterohepatic Circulation of Total Bile Acids in Humans

Overview

Journal CPT Pharmacometrics Syst Pharmacol

Publisher Wiley

Specialty Pharmacology

Date 2018 Aug 3

PMID 30070437

Citations 6

Authors

Benjamin Guiastrennec

David P Sonne

Martin Bergstrand

Tina Vilsboll

Filip K Knop

Mats O Karlsson

Affiliations

Soon will be listed here.

Abstract

Bile acids released postprandially can modify the rate and extent of lipophilic compounds' absorption. This study aimed to predict the enterohepatic circulation (EHC) of total bile acids (TBAs) in response to caloric intake from their spillover in plasma. A model for TBA EHC was combined with a previously developed gastric emptying (GE) model. Longitudinal gallbladder volumes and TBA plasma concentration data from 30 subjects studied after ingestion of four different test drinks were supplemented with literature data. Postprandial gallbladder refilling periods were implemented to improve model predictions. The TBA hepatic extraction was reduced with the high-fat drink. Basal and nutrient-induced gallbladder emptying rates were altered by type 2 diabetes (T2D). The model was predictive of the central trend and the variability of gallbladder volume and TBA plasma concentration for all test drinks. Integration of this model within physiological pharmacokinetic modeling frameworks could improve the predictions for lipophilic compounds' absorption considerably.

Citing Articles

Prediction of Compound Plasma Concentration-Time Profiles in Mice Using Random Forest.

Handa K, Wright P, Yoshimura S, Kageyama M, Iijima T, Bender A Mol Pharm. 2023; 20(6):3060-3072.

PMID: 37096989 PMC: 10245373. DOI: 10.1021/acs.molpharmaceut.3c00071.

Dynamics and determinants of human plasma bile acid profiles during dietary challenges.

Fiamoncini J, Rist M, Frommherz L, Giesbertz P, Pfrang B, Kremer W Front Nutr. 2022; 9:932937.

PMID: 35967802 PMC: 9366195. DOI: 10.3389/fnut.2022.932937.

Application of Differential Network Enrichment Analysis for Deciphering Metabolic Alterations.

Iyer G, Wigginton J, Duren W, LaBarre J, Brandenburg M, Burant C Metabolites. 2020; 10(12).

PMID: 33255384 PMC: 7761243. DOI: 10.3390/metabo10120479.

Population pharmacokinetics of regorafenib in solid tumours: Exposure in clinical practice considering enterohepatic circulation and food intake.

Keunecke A, Hoefman S, Drenth H, Zisowsky J, Cleton A, Ploeger B Br J Clin Pharmacol. 2020; 86(12):2362-2376.

PMID: 32358822 PMC: 7688542. DOI: 10.1111/bcp.14334.

Bilio-enteric flow and plasma concentrations of bile acids after gastric bypass and sleeve gastrectomy.

Eiken A, Fuglsang S, Eiken M, Svane M, Kuhre R, Wewer Albrechtsen N Int J Obes (Lond). 2020; 44(9):1872-1883.

PMID: 32317753 DOI: 10.1038/s41366-020-0578-7.

References

Fiamoncini J, Yiorkas A, Gedrich K, Rundle M, Alsters S, Roeselers G . Determinants of postprandial plasma bile acid kinetics in human volunteers. Am J Physiol Gastrointest Liver Physiol. 2017; 313(4):G300-G312. DOI: 10.1152/ajpgi.00157.2017. View

Engelking L, Barnes S, Dasher C, Naftel D, Hirschowitz B . Radiolabelled bile acid clearance in control subjects and patients with liver disease. Clin Sci (Lond). 1979; 57(6):499-508. DOI: 10.1042/cs0570499. View

Matyja A, Gil K, Pasternak A, Sztefko K, Gajda M, Tomaszewski K . Telocytes: new insight into the pathogenesis of gallstone disease. J Cell Mol Med. 2013; 17(6):734-42. PMC: 3823177. DOI: 10.1111/jcmm.12057. View

Guiastrennec B, Sonne D, Hansen M, Bagger J, Lund A, Rehfeld J . Mechanism-Based Modeling of Gastric Emptying Rate and Gallbladder Emptying in Response to Caloric Intake. CPT Pharmacometrics Syst Pharmacol. 2016; 5(12):692-700. PMC: 5192972. DOI: 10.1002/psp4.12152. View

Howard P, Murphy G, Dowling R . Gall bladder emptying patterns in response to a normal meal in healthy subjects and patients with gall stones: ultrasound study. Gut. 1991; 32(11):1406-11. PMC: 1379178. DOI: 10.1136/gut.32.11.1406. View

Small B, Wendt B, Jamei M, Johnson T . Prediction of liver volume - a population-based approach to meta-analysis of paediatric, adult and geriatric populations - an update. Biopharm Drug Dispos. 2017; 38(4):290-300. DOI: 10.1002/bdd.2063. View

Roberts M, Magnusson B, Burczynski F, Weiss M . Enterohepatic circulation: physiological, pharmacokinetic and clinical implications. Clin Pharmacokinet. 2002; 41(10):751-90. DOI: 10.2165/00003088-200241100-00005. View

Marathe C, Rayner C, Jones K, Horowitz M . Glucagon-like peptides 1 and 2 in health and disease: a review. Peptides. 2013; 44:75-86. DOI: 10.1016/j.peptides.2013.01.014. View

Mould D, Upton R . Basic concepts in population modeling, simulation, and model-based drug development. CPT Pharmacometrics Syst Pharmacol. 2013; 1:e6. PMC: 3606044. DOI: 10.1038/psp.2012.4. View

10.

Anderson B, Holford N . Mechanistic basis of using body size and maturation to predict clearance in humans. Drug Metab Pharmacokinet. 2009; 24(1):25-36. DOI: 10.2133/dmpk.24.25. View

11.

Petersson K, Hanze E, Savic R, Karlsson M . Semiparametric distributions with estimated shape parameters. Pharm Res. 2009; 26(9):2174-85. DOI: 10.1007/s11095-009-9931-1. View

12.

Kostewicz E, Aarons L, Bergstrand M, Bolger M, Galetin A, Hatley O . PBPK models for the prediction of in vivo performance of oral dosage forms. Eur J Pharm Sci. 2013; 57:300-21. DOI: 10.1016/j.ejps.2013.09.008. View

13.

Prawitt J, Caron S, Staels B . Bile acid metabolism and the pathogenesis of type 2 diabetes. Curr Diab Rep. 2011; 11(3):160-6. PMC: 3338411. DOI: 10.1007/s11892-011-0187-x. View

14.

Hofmann A, Molino G, Milanese M, Belforte G . Description and simulation of a physiological pharmacokinetic model for the metabolism and enterohepatic circulation of bile acids in man. Cholic acid in healthy man. J Clin Invest. 1983; 71(4):1003-22. PMC: 436958. DOI: 10.1172/jci110828. View

15.

Charman W, Porter C, Mithani S, Dressman J . Physiochemical and physiological mechanisms for the effects of food on drug absorption: the role of lipids and pH. J Pharm Sci. 1997; 86(3):269-82. DOI: 10.1021/js960085v. View

16.

Fleisher D, Li C, Zhou Y, Pao L, Karim A . Drug, meal and formulation interactions influencing drug absorption after oral administration. Clinical implications. Clin Pharmacokinet. 1999; 36(3):233-54. DOI: 10.2165/00003088-199936030-00004. View

17.

Jazrawi R, Pazzi P, Petroni M, Prandini N, Paul C, Adam J . Postprandial gallbladder motor function: refilling and turnover of bile in health and in cholelithiasis. Gastroenterology. 1995; 109(2):582-91. DOI: 10.1016/0016-5085(95)90348-8. View

18.

Angelin B, Einarsson K, Hellstrom K . Evidence for the absorption of bile acids in the proximal small intestine of normo- and hyperlipidaemic subjects. Gut. 1976; 17(6):420-5. PMC: 1411113. DOI: 10.1136/gut.17.6.420. View

19.

Brouwers J, Augustijns P . Resolving intraluminal drug and formulation behavior: Gastrointestinal concentration profiling in humans. Eur J Pharm Sci. 2014; 61:2-10. DOI: 10.1016/j.ejps.2014.01.010. View

20.

Angelin B, Bjorkhem I . Postprandial serum bile acids in healthy man. Evidence for differences in absorptive pattern between individual bile acids. Gut. 1977; 18(8):606-9. PMC: 1411707. DOI: 10.1136/gut.18.8.606. View